Agios Pharmaceuticals (LTS:0HB0) Short-Term Capital Lease Obligation : $15.41 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Agios Pharmaceuticals Short-Term Capital Lease Obligation?

Agios Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $15.41 Mil.

Agios Pharmaceuticals's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 ($14.66 Mil) to Dec. 2023 ($15.01 Mil) and increased from Dec. 2023 ($15.01 Mil) to Mar. 2024 ($15.41 Mil).

Agios Pharmaceuticals's annual Short-Term Capital Lease Obligation increased from Dec. 2021 ($11.16 Mil) to Dec. 2022 ($13.66 Mil) and increased from Dec. 2022 ($13.66 Mil) to Dec. 2023 ($15.01 Mil).

Agios Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for Agios Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agios Pharmaceuticals Short-Term Capital Lease Obligation Chart

Agios Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

6.92

7.41

11.16

13.66

15.01

Agios Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															13.99	14.33	14.66	15.01	15.41

Agios Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Agios Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Agios Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Agios Pharmaceuticals (LTS:0HB0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Agios Pharmaceuticals Inc (LTS:0HB0) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

AGIO:USA AGIO:Mexico 8AP:Germany 8AP:Germany

Address

88 Sidney Street, Cambridge, MA, USA, 02139

Website

https://www.agios.com

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Agios Pharmaceuticals (LTS:0HB0) Headlines

No Headlines